Heartflow Inc
NASDAQ:HTFL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Heartflow Inc
Capital Expenditures
Heartflow Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
Capital Expenditures
-5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Capital Expenditures
-$29.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-3%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Capital Expenditures
-$38.5m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Capital Expenditures
-$6.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Capital Expenditures
-$60.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-12%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Capital Expenditures
-$26.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Heartflow Inc
Glance View
Heartflow Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Mountain View, California. The company went IPO on 2025-08-08. HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
See Also
What is Heartflow Inc's Capital Expenditures?
Capital Expenditures
-5m
Based on the financial report for Dec 31, 2025, Heartflow Inc's Capital Expenditures amounts to -5m .
What is Heartflow Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 1Y
-15%
Over the last year, the Capital Expenditures growth was -15%.
